Cargando…
Azlocillin can be the potential drug candidate against drug-tolerant Borrelia burgdorferi sensu stricto JLB31
Lyme disease is one of most common vector-borne diseases, reporting more than 300,000 cases annually in the United States. Treating Lyme disease during its initial stages with traditional tetracycline antibiotics is effective. However, 10–20% of patients treated with antibiotic therapy still shows p...
Autores principales: | Pothineni, Venkata Raveendra, Potula, Hari-Hara S. K., Ambati, Aditya, Mallajosyula, Venkata Vamsee Aditya, Sridharan, Brindha, Inayathullah, Mohammed, Ahmed, Mohamed Sohail, Rajadas, Jayakumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052277/ https://www.ncbi.nlm.nih.gov/pubmed/32123189 http://dx.doi.org/10.1038/s41598-020-59600-4 |
Ejemplares similares
-
In vitro and in vivo evaluation of cephalosporins for the treatment of Lyme disease
por: Pothineni, Venkata Raveendra, et al.
Publicado: (2018) -
Identification of new drug candidates against Borrelia burgdorferi using high-throughput screening
por: Pothineni, Venkata Raveendra, et al.
Publicado: (2016) -
Repurposing Disulfiram (Tetraethylthiuram Disulfide) as a Potential Drug Candidate against Borrelia burgdorferi In Vitro and In Vivo
por: Potula, Hari-Hara S. K., et al.
Publicado: (2020) -
Borreliacidal activity of Borrelia metal transporter A (BmtA) binding small molecules by manganese transport inhibition
por: Wagh, Dhananjay, et al.
Publicado: (2015) -
Evidence for Host-Genotype Associations of Borrelia burgdorferi Sensu Stricto
por: Mechai, Samir, et al.
Publicado: (2016)